BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9650432)

  • 1. Malignancy following renal transplantation.
    Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of urologic de novo malignancies after renal transplantation.
    Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
    Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
    Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
    BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan.
    Chiang YJ; Wang HH; Liu KL; Chu SH; Lee WC
    Transplant Proc; 2008 Sep; 40(7):2397-9. PubMed ID: 18790246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid tumors following kidney transplantation in children.
    Smith JM; Martz K; McDonald RA; Harmon WE
    Pediatr Transplant; 2013 Dec; 17(8):726-30. PubMed ID: 24164825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy after renal transplantation: a single-center experience.
    Vrotniakaite K; Jaceviciute R; Rudminiene I; Laucyte-Cibulskiene A; Rainiene T; Jankevicius F; Zelvys A; Miglinas M
    Ann Transplant; 2014 Sep; 19():456-63. PubMed ID: 25223375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
    Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies in organ transplant recipients.
    Hoshida Y; Aozasa K
    Pathol Int; 2004 Sep; 54(9):649-58. PubMed ID: 15363032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in renal transplant recipients.
    Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
    Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
    Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
    Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [De novo malignancy following renal transplantation].
    Suzuki S; Osaka Y; Nakai I; Yasumura T; Omori Y; Oka T
    Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):834-7. PubMed ID: 7830710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea.
    Kim JH; Kim SO; Han DJ; Park SK
    Clin Transplant; 2014 Apr; 28(4):434-42. PubMed ID: 24750289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy after renal transplantation in the new era of immunosuppression.
    Watorek E; Boratynska M; Smolska D; Patrzalek D; Klinger M
    Ann Transplant; 2011; 16(2):14-8. PubMed ID: 21716180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.